Document Detail


Levodopa in Huntingtons chorea.
MedLine Citation:
PMID:  131644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sixteen patients with Huntington's chorea were treated for periods as long as 8 months with levodopa. The condition of none of the patients improved; in fact, there appeared to be an exacerbation of chorea and dementia in addition to undesirable behavioural changes. Therefore, future use of levodopa in these patients is not warranted. The postulated association of low homovanillic acid values in cerebrospinal fluid and favourable response to levodopa therapy was not borne out.
Authors:
S K Sishta; D I Templer
Related Documents :
19103504 - Movement irregularities in atypical parkinsonian syndromes.
12411124 - Clinical course and cause of death in elderly patients with idiopathic parkinson's dise...
21637404 - Normal inflammatory markers in appendicitis: evidence from two independent cohort studies.
3362404 - Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice.
19569974 - Detection of leishmania in unaffected mucosal tissues of patients with cutaneous leishm...
21383624 - Cavernous hemangioma of the liver: factors affecting disease progression in general hep...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian Medical Association journal     Volume:  114     ISSN:  0008-4409     ISO Abbreviation:  Can Med Assoc J     Publication Date:  1976 May 
Date Detail:
Created Date:  1976-08-02     Completed Date:  1976-08-02     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0414110     Medline TA:  Can Med Assoc J     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  798-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Behavior / drug effects
Drug Administration Schedule
Electroencephalography
Female
Homovanillic Acid / cerebrospinal fluid
Humans
Huntington Disease / cerebrospinal fluid,  drug therapy*
Hydroxyindoleacetic Acid / cerebrospinal fluid
Levodopa / adverse effects,  therapeutic use*
Long-Term Care
Male
Middle Aged
Probenecid / diagnostic use
Chemical
Reg. No./Substance:
0/Levodopa; 306-08-1/Homovanillic Acid; 54-16-0/Hydroxyindoleacetic Acid; 57-66-9/Probenecid
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of practolol on experimental hypertension in dogs
Next Document:  Plasma hormone profiles in populations at different risk for breast cancer.